{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:19:24Z","timestamp":1794957564757,"version":"4.9.1"},"publisher-location":"Cham","reference-count":76,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030391409","type":"print"},{"value":"9783030391416","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/7854_2018_88","type":"book-chapter","created":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T04:06:31Z","timestamp":1559793991000},"page":"49-66","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":178,"title":["Cytokines, Oxidative Stress and Cellular Markers of Inflammation in Schizophrenia"],"prefix":"10.1007","author":[{"given":"Rachel","family":"Upthegrove","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Golam M.","family":"Khandaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,22]]},"reference":[{"key":"88_CR1","volume-title":"Diagnostic and statistical manual of mental disorders","author":"APA","year":"2013","unstructured":"APA (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Arlington","edition":"5"},{"key":"88_CR2","volume-title":"Fetal and infant origins of adult disease","author":"DJP Barker","year":"1993","unstructured":"Barker DJP (1993) Fetal and infant origins of adult disease. British Medical Journal, London"},{"issue":"5","key":"88_CR3","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1038\/mp.2015.67","volume":"21","author":"D Baumeister","year":"2016","unstructured":"Baumeister D et al (2016) Childhood trauma and adulthood inflammation: a meta-analysis of peripheral C-reactive protein, interleukin-6 and tumour necrosis factor-alpha. Mol Psychiatry 21(5):642\u2013649","journal-title":"Mol Psychiatry"},{"issue":"1","key":"88_CR4","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.pnpbp.2007.06.031","volume":"32","author":"Q Bian","year":"2008","unstructured":"Bian Q et al (2008) The effect of atypical antipsychotics, perospirone, ziprasidone and quetiapine on microglial activation induced by interferon-\u03b3. Prog Neuro-Psychopharmacol Biol Psychiatry 32(1):42\u201348","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"issue":"2","key":"88_CR5","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/mp.2012.197","volume":"19","author":"AS Brown","year":"2014","unstructured":"Brown AS et al (2014) Elevated maternal C-reactive protein and autism in a national birth cohort. Mol Psychiatry 19(2):259\u2013264","journal-title":"Mol Psychiatry"},{"issue":"10","key":"88_CR6","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1001\/archgenpsychiatry.2011.2094","volume":"69","author":"L Capuron","year":"2012","unstructured":"Capuron L et al (2012) Dopaminergic mechanisms of reduced basal ganglia responses to hedonic reward during interferon alfa administration. Arch Gen Psychiatry 69(10):1044\u20131053","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"88_CR7","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1038\/ng.940","volume":"43","author":"SPG-WAS Consortium","year":"2011","unstructured":"Consortium SPG-WAS (2011) Genome-wide association study identifies five new schizophrenia loci. Nat Genet 43(10):969\u2013976","journal-title":"Nat Genet"},{"issue":"4","key":"88_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2016.40","volume":"6","author":"J Coughlin","year":"2016","unstructured":"Coughlin J et al (2016) In vivo markers of inflammatory response in recent-onset schizophrenia: a combined study using [11 C] DPA-713 PET and analysis of CSF and plasma. Transl Psychiatry 6(4):e777","journal-title":"Transl Psychiatry"},{"key":"88_CR9","first-page":"855","volume":"24","author":"W Dameshek","year":"1930","unstructured":"Dameshek W (1930) White blood cells in dementia praecox and dementia paralytica. Arch Neurol Psychiatr 24:855","journal-title":"Arch Neurol Psychiatr"},{"issue":"1","key":"88_CR10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/nrn2297","volume":"9","author":"R Dantzer","year":"2008","unstructured":"Dantzer R et al (2008) From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci 9(1):46\u201356","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"88_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"G Davey Smith","year":"2003","unstructured":"Davey Smith G, Ebrahim S (2003) \u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32(1):1\u201322","journal-title":"Int J Epidemiol"},{"issue":"11","key":"88_CR12","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/S2215-0366(18)30345-6","volume":"5","author":"B Deakin","year":"2018","unstructured":"Deakin B et al (2018) The benefit of minocycline on negative symptoms of schizophrenia in patients with recent-onset psychosis (BeneMin): a randomised, double-blind, placebo-controlled trial. Lancet Psychiatry 5(11):885\u2013894","journal-title":"Lancet Psychiatry"},{"issue":"1","key":"88_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.schres.2007.03.022","volume":"93","author":"F Dickerson","year":"2007","unstructured":"Dickerson F et al (2007) C-reactive protein is associated with the severity of cognitive impairment but not of psychiatric symptoms in individuals with schizophrenia. Schizophr Res 93(1):261\u2013265","journal-title":"Schizophr Res"},{"issue":"1","key":"88_CR14","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.schres.2012.10.041","volume":"143","author":"F Dickerson","year":"2013","unstructured":"Dickerson F et al (2013) C-reactive protein is elevated in schizophrenia. Schizophr Res 143(1):198\u2013202","journal-title":"Schizophr Res"},{"issue":"6","key":"88_CR15","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.bbi.2006.02.002","volume":"20","author":"\u0141 Drzyzga","year":"2006","unstructured":"Drzyzga \u0141 et al (2006) Cytokines in schizophrenia and the effects of antipsychotic drugs. Brain Behav Immun 20(6):532\u2013545","journal-title":"Brain Behav Immun"},{"issue":"4","key":"88_CR16","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1001\/jamapsychiatry.2013.4374","volume":"71","author":"SA Eraly","year":"2014","unstructured":"Eraly SA et al (2014) Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiat 71(4):423\u2013431","journal-title":"JAMA Psychiat"},{"issue":"11","key":"88_CR17","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1038\/npp.2013.115","volume":"38","author":"JC Felger","year":"2013","unstructured":"Felger JC et al (2013) Chronic interferon-alpha decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primates. Neuropsychopharmacology 38(11):2179\u20132187","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"88_CR18","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/mp.2015.87","volume":"21","author":"B Fernandes","year":"2016","unstructured":"Fernandes B et al (2016) C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: meta-analysis and implications. Mol Psychiatry 21(4):554\u2013564","journal-title":"Mol Psychiatry"},{"issue":"6","key":"88_CR19","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.biopsych.2013.03.018","volume":"74","author":"J Flatow","year":"2013","unstructured":"Flatow J, Buckley P, Miller BJ (2013) Meta-analysis of oxidative stress in schizophrenia. Biol Psychiatry 74(6):400\u2013409","journal-title":"Biol Psychiatry"},{"issue":"1","key":"88_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.schres.2012.01.040","volume":"137","author":"D Fraguas","year":"2012","unstructured":"Fraguas D et al (2012) Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study. Schizophr Res 137(1):58\u201365","journal-title":"Schizophr Res"},{"issue":"1","key":"88_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0165-1781(94)90042-6","volume":"51","author":"R Ganguli","year":"1994","unstructured":"Ganguli R et al (1994) Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness. Psychiatry Res 51(1):1\u201310","journal-title":"Psychiatry Res"},{"issue":"6","key":"88_CR22","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1038\/npp.2017.258","volume":"43","author":"RR Girgis","year":"2018","unstructured":"Girgis RR et al (2018) A randomized, double-blind, placebo-controlled clinical trial of tocilizumab, an interleukin-6 receptor antibody, for residual symptoms in schizophrenia. Neuropsychopharmacology 43(6):1317\u20131323","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"88_CR23","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/mp.2016.3","volume":"21","author":"DR Goldsmith","year":"2016","unstructured":"Goldsmith DR, Rapaport MH, Miller BJ (2016) A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry 21(12):1696\u20131709","journal-title":"Mol Psychiatry"},{"issue":"1","key":"88_CR24","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.biopsych.2015.07.018","volume":"80","author":"NA Harrison","year":"2016","unstructured":"Harrison NA et al (2016) A Neurocomputational account of how inflammation enhances sensitivity to punishments versus rewards. Biol Psychiatry 80(1):73\u201381","journal-title":"Biol Psychiatry"},{"issue":"12","key":"88_CR25","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1001\/jamapsychiatry.2017.3191","volume":"74","author":"FP Hartwig","year":"2017","unstructured":"Hartwig FP et al (2017) Inflammatory biomarkers and risk of schizophrenia: a 2-sample Mendelian randomization study. JAMA Psychiat 74(12):1226\u20131233","journal-title":"JAMA Psychiat"},{"issue":"3","key":"88_CR26","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/schbul\/sbp006","volume":"35","author":"OD Howes","year":"2009","unstructured":"Howes OD, Kapur S (2009) The dopamine hypothesis of schizophrenia: version III \u2013 the final common pathway. Schizophr Bull 35(3):549\u2013562","journal-title":"Schizophr Bull"},{"key":"88_CR27","volume-title":"Immunobiology: the immune system in health and disease","author":"CA Janeway","year":"2001","unstructured":"Janeway CA et al (2001) Immunobiology: the immune system in health and disease, 5th edn. Garland Science, New York","edition":"5"},{"issue":"12","key":"88_CR28","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.4088\/JCP.14r09179","volume":"76","author":"S Jim\u00e9nez-Fern\u00e1ndez","year":"2015","unstructured":"Jim\u00e9nez-Fern\u00e1ndez S et al (2015) Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis. J Clin Psychiatry 76(12):1658\u20131667","journal-title":"J Clin Psychiatry"},{"issue":"1","key":"88_CR29","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12888-016-0769-x","volume":"16","author":"E Johnsen","year":"2016","unstructured":"Johnsen E et al (2016) The serum level of C-reactive protein (CRP) is associated with cognitive performance in acute phase psychosis. BMC Psychiatry 16(1):60","journal-title":"BMC Psychiatry"},{"issue":"1","key":"88_CR30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1440-1711.2005.01305.x","volume":"83","author":"AL Jones","year":"2005","unstructured":"Jones AL et al (2005) Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis? Immunol Cell Biol 83(1):9\u201317","journal-title":"Immunol Cell Biol"},{"key":"88_CR31","first-page":"1","volume":"49","author":"N Kappelmann","year":"2018","unstructured":"Kappelmann N et al (2018a) Systemic inflammation and intelligence in early adulthood and subsequent risk of schizophrenia and other non-affective psychoses: a longitudinal cohort and co-relative study. Psychol Med 49:1\u20138","journal-title":"Psychol Med"},{"issue":"2","key":"88_CR32","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/mp.2016.167","volume":"23","author":"N Kappelmann","year":"2018","unstructured":"Kappelmann N et al (2018b) Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions. Mol Psychiatry 23(2):335\u2013343","journal-title":"Mol Psychiatry"},{"issue":"9","key":"88_CR33","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1007\/s00213-015-3975-1","volume":"233","author":"GM Khandaker","year":"2016","unstructured":"Khandaker GM, Dantzer R (2016) Is there a role for immune-to-brain communication in schizophrenia? Psychopharmacology 233(9):1559\u20131573","journal-title":"Psychopharmacology"},{"issue":"10","key":"88_CR34","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/jamapsychiatry.2014.1332","volume":"71","author":"GM Khandaker","year":"2014","unstructured":"Khandaker GM et al (2014) Association of serum interleukin 6 and C-reactive protein in childhood with depression and psychosis in young adult life: a population-based longitudinal study. JAMA Psychiat 71(10):1121\u20131128","journal-title":"JAMA Psychiat"},{"issue":"3","key":"88_CR35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","volume":"2","author":"GM Khandaker","year":"2015","unstructured":"Khandaker GM et al (2015) Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment. Lancet Psychiatry 2(3):258\u2013270","journal-title":"Lancet Psychiatry"},{"issue":"13","key":"88_CR36","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1017\/S0033291717000745","volume":"47","author":"GM Khandaker","year":"2017","unstructured":"Khandaker GM, Dantzer R, Jones PB (2017) Immunopsychiatry: important facts. Psychol Med 47(13):2229\u20132237","journal-title":"Psychol Med"},{"key":"88_CR37","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.bbi.2017.11.020","volume":"69","author":"GM Khandaker","year":"2018","unstructured":"Khandaker GM et al (2018a) Association between a functional interleukin 6 receptor genetic variant and risk of depression and psychosis in a population-based birth cohort. Brain Behav Immun 69:264\u2013272","journal-title":"Brain Behav Immun"},{"key":"88_CR38","unstructured":"Khandaker GM et al (2018b) Positive and negative symptoms of psychosis associated with circulating C-reactive protein: unravelling trans-diagnostic effect of inflammation (under review)"},{"key":"88_CR39","unstructured":"Khandaker GM et al (2018c) Influence of prenatal maternal depression on circulating inflammatory markers and risks of depression and psychosis in offspring: a prospective birth cohort study. Psychoneuroendocrinology (in press)"},{"issue":"1","key":"88_CR40","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.psyneuen.2008.08.016","volume":"34","author":"M Kluge","year":"2009","unstructured":"Kluge M et al (2009) Effects of clozapine and olanzapine on cytokine systems are closely linked to weight gain and drug-induced fever. Psychoneuroendocrinology 34(1):118\u2013128","journal-title":"Psychoneuroendocrinology"},{"key":"88_CR41","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1192\/bjp.bp.117.201475","volume":"211","author":"J Lally","year":"2017","unstructured":"Lally J et al (2017) Remission and recovery from first-episode psychosis in adults: systematic review and meta-analysis of long-term outcome studies. Br J Psychiatry 211:350\u2013358","journal-title":"Br J Psychiatry"},{"issue":"2","key":"88_CR42","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/YIC.0b013e32833643fd","volume":"25","author":"S L\u00f6ffler","year":"2010","unstructured":"L\u00f6ffler S et al (2010) Clozapine therapy raises serum concentrations of high sensitive C-reactive protein in schizophrenic patients. Int Clin Psychopharmacol 25(2):101\u2013106","journal-title":"Int Clin Psychopharmacol"},{"issue":"4","key":"88_CR43","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1006\/cyto.1997.0290","volume":"10","author":"M Maes","year":"1998","unstructured":"Maes M et al (1998) The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine 10(4):313\u2013318","journal-title":"Cytokine"},{"issue":"1","key":"88_CR44","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0920-9964(95)00049-6","volume":"19","author":"SP Mahadik","year":"1996","unstructured":"Mahadik SP, Mukherjee S (1996) Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophr Res 19(1):1\u201317","journal-title":"Schizophr Res"},{"issue":"1","key":"88_CR45","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1093\/schbul\/sbr069","volume":"39","author":"A Marsman","year":"2013","unstructured":"Marsman A et al (2013) Glutamate in schizophrenia: a focused review and meta-analysis of 1H-MRS studies. Schizophr Bull 39(1):120\u2013129","journal-title":"Schizophr Bull"},{"key":"88_CR46","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.schres.2017.09.040","volume":"195","author":"J McGinty","year":"2018","unstructured":"McGinty J, Haque MS, Upthegrove R (2018) Depression during first episode psychosis and subsequent suicide risk: a systematic review and meta-analysis of longitudinal studies. Schizophr Res 195:58\u201366","journal-title":"Schizophr Res"},{"key":"88_CR47","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.bbi.2016.09.008","volume":"59","author":"SA Metcalf","year":"2017","unstructured":"Metcalf SA et al (2017) Serum C-reactive protein in adolescence and risk of schizophrenia in adulthood: a prospective birth cohort study. Brain Behav Immun 59:253\u2013259","journal-title":"Brain Behav Immun"},{"issue":"9","key":"88_CR48","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.biopsych.2008.11.029","volume":"65","author":"AH Miller","year":"2009","unstructured":"Miller AH, Maletic V, Raison CL (2009) Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry 65(9):732\u2013741","journal-title":"Biol Psychiatry"},{"issue":"7","key":"88_CR49","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.biopsych.2011.04.013","volume":"70","author":"BJ Miller","year":"2011","unstructured":"Miller BJ et al (2011) Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects. Biol Psychiatry 70(7):663\u2013671","journal-title":"Biol Psychiatry"},{"issue":"4","key":"88_CR50","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3371\/CSRP.MICU.020813","volume":"7","author":"BJ Miller","year":"2013","unstructured":"Miller BJ, Culpepper N, Rapaport MH (2013) C-reactive protein levels in schizophrenia: a review and meta-analysis. Clin Schizophr Relat Psychoses 7(4):223\u2013230","journal-title":"Clin Schizophr Relat Psychoses"},{"issue":"2","key":"88_CR51","doi-asserted-by":"publisher","first-page":"275","DOI":"10.4088\/JCP.15l09920","volume":"77","author":"BJ Miller","year":"2016","unstructured":"Miller BJ et al (2016) An open-label, pilot trial of adjunctive tocilizumab in schizophrenia. J Clin Psychiatry 77(2):275\u2013276","journal-title":"J Clin Psychiatry"},{"issue":"5","key":"88_CR52","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1093\/schbul\/sbv028","volume":"41","author":"V Mondelli","year":"2015","unstructured":"Mondelli V et al (2015) Cortisol and inflammatory biomarkers predict poor treatment response in first episode psychosis. Schizophr Bull 41(5):1162\u20131170","journal-title":"Schizophr Bull"},{"key":"88_CR53","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.psychres.2011.12.049","volume":"198","author":"N M\u00fcller","year":"2012","unstructured":"M\u00fcller N et al (2012) Impaired monocyte activation in schizophrenia. Psychiatry Res 198:341\u2013346","journal-title":"Psychiatry Res"},{"issue":"6600","key":"88_CR54","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1136\/bmj.295.6600.681","volume":"295","author":"RM Murray","year":"1987","unstructured":"Murray RM, Lewis SW (1987) Is schizophrenia a neurodevelopmental disorder? BMJ (Clin Res Ed) 295(6600):681\u2013682","journal-title":"BMJ (Clin Res Ed)"},{"issue":"1","key":"88_CR55","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.schres.2015.01.026","volume":"164","author":"C Noto","year":"2015","unstructured":"Noto C et al (2015) Effects of depression on the cytokine profile in drug naive first-episode psychosis. Schizophr Res 164(1):53\u201358","journal-title":"Schizophr Res"},{"issue":"2","key":"88_CR56","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1093\/schbul\/sby040","volume":"45","author":"Benjamin Ian Perry","year":"2018","unstructured":"Perry BI et al (2018) Dysglycaemia, inflammation and psychosis: findings from the UK ALSPAC birth cohort. Schizophr Bull. https:\/\/doi.org\/10.1093\/schbul\/sby040","journal-title":"Schizophrenia Bulletin"},{"issue":"3","key":"88_CR57","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1001\/jama.286.3.327","volume":"286","author":"AD Pradhan","year":"2001","unstructured":"Pradhan AD et al (2001) C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286(3):327\u2013334","journal-title":"JAMA"},{"issue":"1","key":"88_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-244X-11-124","volume":"11","author":"M Raffa","year":"2011","unstructured":"Raffa M et al (2011) Decreased glutathione levels and impaired antioxidant enzyme activities in drug-naive first-episode schizophrenic patients. BMC Psychiatry 11(1):1","journal-title":"BMC Psychiatry"},{"issue":"1","key":"88_CR59","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1001\/2013.jamapsychiatry.4","volume":"70","author":"CL Raison","year":"2013","unstructured":"Raison CL et al (2013) A randomized controlled trial of the tumor necrosis factor antagonist infliximab for treatment-resistant depression: the role of baseline inflammatory biomarkers. JAMA Psychiat 70(1):31\u201341","journal-title":"JAMA Psychiat"},{"issue":"1","key":"88_CR60","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.schres.2012.06.020","volume":"140","author":"R R\u00f8ge","year":"2012","unstructured":"R\u00f8ge R et al (2012) Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far? Schizophr Res 140(1):204\u2013213","journal-title":"Schizophr Res"},{"key":"88_CR61","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.bbi.2015.06.004","volume":"49","author":"A Russell","year":"2015","unstructured":"Russell A et al (2015) Inflammation and metabolic changes in first episode psychosis: preliminary results from a longitudinal study. Brain Behav Immun 49:25\u201329","journal-title":"Brain Behav Immun"},{"issue":"2","key":"88_CR62","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.10265","volume":"52","author":"R Schmidt","year":"2002","unstructured":"Schmidt R et al (2002) Early inflammation and dementia: a 25-year follow-up of the Honolulu-Asia aging study. Ann Neurol 52(2):168\u2013174","journal-title":"Ann Neurol"},{"issue":"1\u20133","key":"88_CR63","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.schres.2013.09.011","volume":"151","author":"Y Seki","year":"2013","unstructured":"Seki Y et al (2013) Pretreatment of aripiprazole and minocycline, but not haloperidol, suppresses oligodendrocyte damage from interferon-gamma-stimulated microglia in co-culture model. Schizophr Res 151(1\u20133):20\u201328","journal-title":"Schizophr Res"},{"issue":"3","key":"88_CR64","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1124\/pr.109.002451","volume":"62","author":"SF Traynelis","year":"2010","unstructured":"Traynelis SF et al (2010) Glutamate receptor ion channels: structure, regulation, and function. Pharmacol Rev 62(3):405\u2013496","journal-title":"Pharmacol Rev"},{"issue":"2","key":"88_CR65","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1192\/apt.bp.113.011452","volume":"20","author":"R Upthegrove","year":"2014","unstructured":"Upthegrove R, Barnes NM (2014) The immune system and schizophrenia: an update for clinicians. Adv Psychiatr Treat 20(2):83\u201391","journal-title":"Adv Psychiatr Treat"},{"issue":"1\u20133","key":"88_CR66","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.schres.2014.03.005","volume":"155","author":"R Upthegrove","year":"2014","unstructured":"Upthegrove R, Manzanares-Teson N, Barnes NM (2014) Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis. Schizophr Res 155(1\u20133):101\u2013108","journal-title":"Schizophr Res"},{"key":"88_CR67","first-page":"240","volume":"43","author":"R Upthegrove","year":"2017","unstructured":"Upthegrove R, Marwaha S, Birchwood M (2017) Depression and schizophrenia: cause, consequence or trans-diagnostic issue? Schizophr Bull 43:240\u2013244","journal-title":"Schizophr Bull"},{"issue":"2","key":"88_CR68","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1017\/S0033291708003814","volume":"39","author":"J van Os","year":"2009","unstructured":"van Os J et al (2009) A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med 39(2):179","journal-title":"Psychol Med"},{"issue":"7321","key":"88_CR69","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/nature09563","volume":"468","author":"J van Os","year":"2010","unstructured":"van Os J, Kenis G, Rutten BP (2010) The environment and schizophrenia. Nature 468(7321):203\u2013212","journal-title":"Nature"},{"issue":"1","key":"88_CR70","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1093\/schbul\/sbx035","volume":"44","author":"AK Wang","year":"2018","unstructured":"Wang AK, Miller BJ (2018) Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression. Schizophr Bull 44(1):75\u201383","journal-title":"Schizophr Bull"},{"key":"88_CR71","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.schres.2017.03.041","volume":"192","author":"L-J Wang","year":"2018","unstructured":"Wang L-J et al (2018) Increased serum levels of cysteine in patients with schizophrenia: a potential marker of cognitive function preservation. Schizophr Res 192:391\u2013397","journal-title":"Schizophr Res"},{"issue":"7","key":"88_CR72","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/archpsyc.1987.01800190080012","volume":"44","author":"DR Weinberger","year":"1987","unstructured":"Weinberger DR (1987) Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44(7):660\u2013669","journal-title":"Arch Gen Psychiatry"},{"issue":"5","key":"88_CR73","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1093\/schbul\/sbt120","volume":"40","author":"MK Wium-Andersen","year":"2014","unstructured":"Wium-Andersen MK, Orsted DD, Nordestgaard BG (2014) Elevated C-reactive protein associated with late- and very-late-onset schizophrenia in the general population: a prospective study. Schizophr Bull 40(5):1117\u20131127","journal-title":"Schizophr Bull"},{"issue":"12","key":"88_CR74","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.biopsych.2013.11.029","volume":"75","author":"ES Wohleb","year":"2014","unstructured":"Wohleb ES et al (2014) Re-establishment of anxiety in stress-sensitized mice is caused by monocyte trafficking from the spleen to the brain. Biol Psychiatry 75(12):970\u2013981","journal-title":"Biol Psychiatry"},{"issue":"5","key":"88_CR75","doi-asserted-by":"crossref","first-page":"396","DOI":"10.47102\/annals-acadmedsg.V38N5p396","volume":"38","author":"SJ Wood","year":"2009","unstructured":"Wood SJ et al (2009) Neurobiology of schizophrenia spectrum disorders: the role of oxidative stress. Ann Acad Med Singap 38(5):396\u2013401","journal-title":"Ann Acad Med Singap"},{"issue":"13","key":"88_CR76","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1093\/eurheartj\/ehq103","volume":"31","author":"J Zacho","year":"2010","unstructured":"Zacho J, Tybjaerg-Hansen A, Nordestgaard BG (2010) C-reactive protein and all-cause mortality \u2013 the Copenhagen city heart study. Eur Heart J 31(13):1624\u20131632","journal-title":"Eur Heart J"}],"container-title":["Current Topics in Behavioral Neurosciences","Neuroinflammation and Schizophrenia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/7854_2018_88","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T03:05:39Z","timestamp":1694919939000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/7854_2018_88"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030391409","9783030391416"],"references-count":76,"URL":"https:\/\/doi.org\/10.1007\/7854_2018_88","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.735821112.793581109","asserted-by":"object"}],"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-3-030-39141-6","asserted-by":"object"}]},"ISSN":["1866-3370","1866-3389"],"issn-type":[{"value":"1866-3370","type":"print"},{"value":"1866-3389","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"22 May 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}